Eli Lilly signs deals to boost supply of COVID-19 treatment in India

Eli Lilly and Co (LLY.N) said on Monday it had signed licensing agreements with three Indian generic drugmakers to expand the availability of its arthritis drug baricitinib in the country for treating COVID-19 patients. The agreements will bolster India's arsenal of drugs to battle its catastrophic second wave of the...